rs368533266
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BS1_SupportingBP4BS3_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_001114753.3: c.1316A>C variant in ENG is a missense variant predicted to cause substitution of lysine by threonine at amino acid 439 (p.Lys439Thr). The filtering allele frequency (the lower threshold of the 95% CI of 15/10368) of the c.1316A>C variant in ENG is 0.0008918 for Ashkenazi Jewish chromosomes by gnomAD v2.1.1, which is higher than the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel threshold (>0.0008-0.002) for BS1_Supporting, and therefore meets this criterion (BS1_Supporting). The computational predictor REVEL gives a score of 0.041, which is below the threshold of ≤0.15, and the splice site predictor SpliceAI indicated that the variant has no impact on splicing, evidence that does not predict a damaging effect on ENG function (BP4). Additionally, functional assays showed the variant protein localized to the cell surface and had normal BMP9 response indicating that this variant does not impact protein function (BS3_Supporting; PMID:25312062). In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: BS1_Supporting, BP4, BS3_Supporting (specification version 1.0.0; 1/4/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA5252800/MONDO:0008535/136
Frequency
Consequence
NM_001114753.3 missense
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- hereditary hemorrhagic telangiectasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- juvenile polyposis syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001114753.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ENG | MANE Select | c.1316A>C | p.Lys439Thr | missense | Exon 11 of 15 | NP_001108225.1 | P17813-1 | ||
| ENG | c.1316A>C | p.Lys439Thr | missense | Exon 11 of 14 | NP_000109.1 | Q5T9B9 | |||
| ENG | c.770A>C | p.Lys257Thr | missense | Exon 11 of 15 | NP_001265067.1 | F5GX88 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ENG | TSL:1 MANE Select | c.1316A>C | p.Lys439Thr | missense | Exon 11 of 15 | ENSP00000362299.4 | P17813-1 | ||
| ENG | TSL:1 | c.1316A>C | p.Lys439Thr | missense | Exon 11 of 14 | ENSP00000341917.3 | P17813-2 | ||
| ENG | c.1316A>C | p.Lys439Thr | missense | Exon 11 of 15 | ENSP00000519338.1 | A0AAQ5BHC4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152032Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000131 AC: 33AN: 251416 AF XY: 0.000140 show subpopulations
GnomAD4 exome AF: 0.0000897 AC: 131AN: 1459986Hom.: 0 Cov.: 31 AF XY: 0.000109 AC XY: 79AN XY: 726294 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152032Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74258 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at